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Forward genetic screens for mutant organisms provide a powerful tool for understanding the molecular basis underlying a plethora of biological processes. The specific advantages of the model organism *Caenorhabditis elegans*, such as self-fertilization, short generation time, transparency and ease of handling, prompted its extensive use in forward genetic screens that have yielded valuable insights into animal development and physiology [@R1],[@R2]. Depending on the phenotype screened for, the actual isolation of mutants can be a major limitation in a forward genetic analysis. For example, the screening for mutants in which individual cellular fates, visualized by *gfp*-based reporter gene technology [@R3], are not appropriately executed, can be a tedious undertaking. A technology that bears promise to automate the phenotypic assessment step in cell fate screens is the COPAS Biosort system (Union Biometrica; "worm sorter"). The worm sorter is a flow cytometry instrument adjusted to analyze and sort small living organisms the size of *C. elegans* on the basis of their optical density, size, and fluorescence [@R4]. The worm sorter has not been previously tested for isolating mutants that fail to execute specific cellular fates visualized by *gfp* reporters. The very nature of the conventional fluorescence-based screen for cell-fate mutants poses specific challenges for this technology as such screens often require the detection of animals in which only a small number of cells is labeled with a cell type-specific fluorescent marker. Moreover, desirable mutants may only lose marker gene expression in a subset of cells, and the overall changes in fluorescent intensity may therefore be subtle. Testing the performance of the COPAS Biosort system in such specific conditions is necessary for assessing its applicability in screens for cell fate mutants.

We describe here the use of the COPAS Biosort machine in a forward genetic screen for mutants defective in executing the dopaminergic cell fate. Dopaminergic neurons fulfill important functions across phylogeny, yet the genetic pathways that control dopaminergic cell fate are poorly understood to date [@R5]. A *gfp* reporter fusion to the promoter of the dopamine neuron-specific [d]{.ul}op[a]{.ul}mine re-uptake [t]{.ul}ransporter *dat-1* exclusively labels all dopaminergic neurons in *vtIs1 \[dat-1*∷*gfp\]*, a transgenic strain that expresses *gfp* exclusively in all 8 dopaminergic neurons of the worm [@R14] [@R6] ([Fig. 1a](#F1){ref-type="fig"}). As there are only eight dopaminergic neurons in the \~1000 cell-containing *C.elegans* hermaphrodite, the use of *dat-1*∷*gfp* provides a challenging test system for the sensitivity of the worm sorter. We performed test runs to determine whether these eight cells provide enough signal strength for the worm sorter. We first ran a sorting test in which the transgenic strain carrying *dat-1*∷*gfp* was mixed with non-transgenic, i.e. non-*gfp* expressing worms. Non-transgenic animals could indeed be sorted out efficiently ([Supplementary Table 1](#SD1){ref-type="supplementary-material"}). To control for the variability in fluorescent intensities among transgenic individuals, we introduced a chromosomally integrated, broadly expressed *rfp* transgene (*vsIs33 \[dop-3*∷*rfp\]*)[@R7] in the background of our screening strain as an internal reference of fluorescence intensity. This strain expresses *rfp* in some body-wall muscles and in various head neurons, ventral nerve cord neurons, tail neurons, and two mechanosensory neurons -the PVDs- but not in dopaminergic neurons ([Fig. 1b](#F1){ref-type="fig"}). The sorter was set to compare fluorescence between green and red channels and plot their ratio. The sorting region was set to isolate individuals with reduced green to red ratio of fluorescence. This substantially increased the efficiency of sorting *gfp* negative animals ([Supplementary Table 1](#SD1){ref-type="supplementary-material"}).

To test the practicability of the worm sorter-based genetic screens for dopaminergic fate mutants, we conducted two different genetic screens for EMS-induced mutations, a manual one and an automated worm sorter screen, and compared the outcomes. For the manual F~1~ clonal screen we mutagenized animals with EMS, singled F~1~ progeny onto individual plates and screened through their progeny with the help of a stereo dissecting microscope with a fluorescent light source ([Fig. 1c](#F1){ref-type="fig"}). We screened through 11,000 EMS-mutagenized haploid genomes in the course of several months and identified 10 mutants that express *dat-1*∷*gfp* in fewer cells than normal ([Table 2](#T2){ref-type="table"}).

In the automated screen we screened through approximately 80,000 EMS-mutagenized haploid genomes with the COPAS Biosort instrument ([Fig. 1d](#F1){ref-type="fig"}), focusing on isolating mutants that show reduced *gfp* expression. [Figure 1e,f](#F1){ref-type="fig"} shows an example of a fluorescence distribution graph of a mutagenized population, in which some animals show reduced green to red ratio compared to wild-type animals. The animals falling into the sorting region (arrows in [Fig. 1f](#F1){ref-type="fig"}) were sorted out by the COPAS instrument onto a plate and were then inspected under a fluorescence stereoscope to confirm the presence of a phenotype.

We identified 22 mutants with reduced *gfp* expression. 3 mutants were isolated in which the overall *gfp* expression level was merely reduced in all 8 dopaminergic neurons (data not shown) and 2 mutants showed complete loss of *gfp* expression, but proved to be mutations in the transgenic array (see [Supplementary Methods](#SD1){ref-type="supplementary-material"}); both mutant classes were not further considered. The remaining 17 show a reduced number of cells expressing *gfp* in at least one class of dopaminergic neurons. The mutants show striking cellular specificity, with individual mutants affecting distinct subsets of dopaminergic neurons; one mutant affects as little as one subclass of the eight dopaminergic neurons ([Table 1](#T1){ref-type="table"}). The sorting profiles of homozygous population of some of these mutants are presented in [Fig. 1g-j](#F1){ref-type="fig"}.

We mapped the mutants retrieved from both screens using high throughput SNP mapping [@R8], performed complementation tests (data not shown) and sequenced candidate genes in the regions in which we mapped individual mutants. In total, we recovered 6 alleles of the Math/atonal-like bHLH gene *lin-32*, previously known to play a role in specifying one subtype of dopaminergic neurons [@R9], but not previously known to also affect the specification of other dopaminergic neurons ([Table 2](#T2){ref-type="table"}, [Supplementary Fig.1](#SD1){ref-type="supplementary-material"} and [Supplementary Table 2](#SD1){ref-type="supplementary-material"}). We recovered one allele of the *Pax6/Eyeless*-like gene *vab-3* [@R10], which had not previously been implicated in dopamine neuron development ([Table 2](#T2){ref-type="table"}, [Supplementary Fig. 2](#SD1){ref-type="supplementary-material"} and [Supplementary Table 3](#SD1){ref-type="supplementary-material"}) and eight alleles of the *ham-1* gene, previously known to be involved in controlling asymmetric cell divisions [@R11] ([Table 2](#T2){ref-type="table"}, [Supplementary Fig. 2](#SD1){ref-type="supplementary-material"} and [Supplementary Table 4](#SD1){ref-type="supplementary-material"}). In addition to these known genes, we isolated a number of additional, apparently novel mutants that fall into six complementation groups that we mapped to different chromosomal locations ([Table 2](#T2){ref-type="table"}, [Fig. 2](#F2){ref-type="fig"} and [Supplementary Fig. 1](#SD1){ref-type="supplementary-material"}). We termed these genes "*dopy*" for "*[dop]{.ul}* aminergic neuron at*[y]{.ul}*pical". *dopy* mutants appear to affect *dat-1*∷*gfp* expression in a cell-type specific manner, suggesting that on some level, there is differential regulation of the dopaminergic fate among the various classes of dopaminergic neurons (**Fig. 2h**). Based on the allele recovery rate, we estimate that our worm sorter screen has reached at least 78% saturation ([Supplementary Table 5](#SD1){ref-type="supplementary-material"}).

Comparing the manual and automated screening approach, we find that the worm sorter screen is more efficient in several regards. First, as less worm picking is involved, the preparation of mutagenized worms for screening with the sorter requires much less operating time than in the manual screen (compare procedures in [Fig. 1c and 1d](#F1){ref-type="fig"}). Moreover, in the actual screening process, it takes about one hour of intense effort at the stereomicroscope to screen through 60 mutagenized genomes (for which \~1,000 individual worms need to be screened in our screening design) while the worm sorter can screen up to 2,000 mutagenized genomes (\~50,000 individual worms) in the same amount of time ([Table 2](#T2){ref-type="table"}). Considering the total amount of time we invested in each screening strategy, the work load was on average ten laborious days of manual screen at the stereomicroscope per isolated mutant as opposed to one and a half part-time days that involve mostly casual supervision of the proper function of the COPAS Biosort machine ([Table 2](#T2){ref-type="table"}; see [Supplementary Methods](#SD1){ref-type="supplementary-material"} for details). This high-throughput screening rate of the COPAS method is unprecedented as the only other technology available for automated mutant isolation, the use of microfluids [@R12], offers a screening speed that is orders of magnitude lower (few hundred animals per hour as opposed to several thousands).

Comparison of the spectrum of mutants retrieved by manual and automated screening further illustrates the effectiveness and sensitivity of the worm sorter approach. While we retrieved alleles of two loci (*lin-32, ham-1*) by both the manual and automated screen (with more alleles retrieved by the latter), four loci (*dopy-2, dopy-3, dopy-7, vab-3*) were retrieved exclusively by the automated screen. This is likely because we were able to screen through a larger number of mutagenized genomes. These mutant alleles would have likely surfaced in manual screens as well, but those mutants would have taken much more time to isolate. The sensitivity of the worm sorter is further illustrated by its ability to recognize mutants with as little as one cell having lost *gfp* expression ([Table 1](#T1){ref-type="table"}). Three loci were only retrieved by the manual screen for reasons explained in the legend to [Table 2](#T2){ref-type="table"}.

In conclusion, we have demonstrated that the worm sorter can be used to automate the phenotypic selection step in cell fate screens. This approach can be used for a variety of different cell fate markers; for example, we have also used the worm sorter to isolate mutants with aberrant expression of neuronal fate markers normally only expressed in two (AIYL and AIYR) or as little as one (ASEL) neuronal subtypes (V. Bertrand, F. Zhang, M.D. and O.H., unpub. data). Use of the worm sorter dramatically speeds up the screening process and, in the case described here in detail, identified a variety of mutants that displayed abnormal dopaminergic neuron differentiation. An implicit feature of automation is scalability. Given the minimal effort involved in growing and sorting worms, one can interrogate the genome to an as saturating degree as any mutagenesis approach may allow. In combination with the recently developed strategies which allow for easy identification of the molecular lesion such as transposon tagging[@R13], or whole genome sequencing (**Sarin et al., accompanying paper**), worm sorter based screens will enable an exhaustive analysis of genetic pathways involved in development.
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![Screening for dopaminergic cell fate mutants\
(**a, b**) Transgenic strains used for the worm sorter screen. Scale bar represents 100 μm. (**c**) Experimental procedure of the manual screen. (**d**) Experimental procedure of the COPAS worm sorter screen. (**e**)-(**j**) Relative fluorescence intensity plots between red and green channels of sorted worms. Scale is defined by the sorting parameters (see [Supplementary Methods](#SD1){ref-type="supplementary-material"}). Each dot corresponds to a single worm. (**e**) Profile of a non-mutagenized population of the sorting strain. (**f**) Example profile of a mutagenized population of worms. Red arrows indicate individual animals that fall into the manually-set sorting window. (**g-j**) Profiles of homogenous populations of retrieved mutants: (**g**) *ot344* (0 out of 8 cells expressing *gfp*), (**h**) *ot337* (2-4 out of 8 cells expressing *gfp*), (**i**) *ot406* (4-6 out of 8 cells expressing *gfp*), and (**j**) *ot346* (7-9 out of 8 cells expressing *gfp*). The triangle area at the bottom right of each panel is an example of a sorting region chosen to demonstrate the profile differences between various populations. The actual sorting region used in the screening process was usually larger, to minimize the possibility of loosing mutants.](nihms-95290-f0001){#F1}

![Phenotypes of isolated *dopy* mutants\
Micrographs of representative wild-type **(a)** and mutant animals (**b)** expressing *dat-1*∷*gfp*. Scale bars represent 10 μm. See [Supplementary Fig. 1](#SD1){ref-type="supplementary-material"} for additional mutants and quantification of data. (**c**) Schematic summary of cell-type specificity of dopaminergic mutant phenotypes.](nihms-95290-f0002){#F2}

###### 

Types of phenotypes retrieved using the worm sorter

  Number of cells expressing *gfp*   Number of alleles   Allele name
  ---------------------------------- ------------------- ---------------------------------------------------
  0 out of 8                         2                   *ot344, ot373* (array mutations)
  2 out of 8                         3                   *ot399, ot347, ot366*
  3 out of 8                         1                   *ot337*
  4 out of 8                         5                   *ot340, ot406, ot341, ot343, ot338*
  6 out of 8                         7                   *ot342, ot361, ot367, ot339, ot371, ot363, ot346*
  7 out of 8                         1                   *ot345*

For mutants displaying multiple phenotypes (see [Supplementary Fig. 2](#SD1){ref-type="supplementary-material"}), we consider here only the phenotype on the basis of which the mutant was isolated.

###### 

Mutants retrieved from genetic screens

  Gene name                                 Molecular identity                         Manual screen                                  Sorter screen   Allele names                                               Dom/Rec   Pleiotropies
  ----------------------------------------- ------------------------------------------ ---------------------------------------------- --------------- ---------------------------------------------------------- --------- --------------
  *dopy-2*                                  unknown                                    0 alleles                                      3 alleles       *ot340, ot345 ot406*                                       R         \-
  *dopy-3*                                  unknown                                    0 alleles                                      1 allele        *ot337*                                                    D         \-
  *dopy-4*                                  unknown                                    1 allele [\*](#TFN2){ref-type="table-fn"}      0 alleles       *ot260*                                                    R         \-
  *dopy-5*                                  unknown                                    4 alleles [\*\*](#TFN3){ref-type="table-fn"}   0 alleles       *ot283, ot284, ot296, ot298*                               R         sterile
  *dopy-6*                                  unknown                                    1 allele [\*](#TFN2){ref-type="table-fn"}      0 alleles       *ot263*                                                    R         \-
  *dopy-7*                                  unknown                                    0 alleles                                      2 alleles       *ot399, ot347*                                             R         sick
  *lin-32*                                  bHLH                                       2 alleles                                      4 alleles       *ot259, ot297, ot341, ot343, ot338, ot366*                 R         \-
  *ham-1*                                   no homologies                              2 alleles                                      6 alleles       *ot253, ot257, ot342, ot361, ot367, ot339, ot371, ot364*   R         \-
  *vab-3*                                   paired + homeodomain                       0 alleles                                      1 allele        *ot346*                                                    R         notched head
  **Total allele number**                   10                                         17                                                                                                                                  
  **Genomes screened**                      11,000                                     80,000                                                                                                                              
  **Allele frequency per genomes screen**   1/1,100                                    1/4,700                                                                                                                             
  **Time investment**                       100 days [§](#TFN1){ref-type="table-fn"}   25 days [§](#TFN1){ref-type="table-fn"}                                                                                             
  **Allele frequency per time**             1 allele / 10 days                         1 allele / 1.5 days                                                                                                                 

Dom/Rec indicates "dominant/recessive".

These days are differentially spent. 100 days dissecting scope work mean full time work at the microscope while 25 days of worm sorting involves mainly machine running and casual observation of functioning of sorter.

As these two mutants only affect *gfp* expression in the 2 PDE neurons, it is possible that these two mutants were only retrieved by the manual screen because *gfp* expression in the PDEs is dimmer than in the other dopaminergic neurons and a loss of *gfp* expression only in these neurons is the most challenging phenotype to detect. In fact, one of the two missing PDE mutants was isolated in the manual screen only for its concurrent \`extra PDEs\' phenotype (see quantification of phenotypic data in [Fig. 2](#F2){ref-type="fig"}).

This sterile mutant was not isolated by the worm sorter screen because we did not pursue sorted mutants that could not easily be maintained as homozygotes. In contrast to semi-clonal manual screens, in which it is easy to maintain a sterile mutant strain by identifying and maintaining heterozygous adult animals from the parental plate, plates that were analyzed by the worm sorter contained significantly more complex population of mutants, which makes the re-isolation of the parents labor intensive, though still possible in principle.

A more comprehensive version of this table is presented in [Supplementary Table 6](#SD1){ref-type="supplementary-material"}.
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